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Background: Three-dimensional ultrasound (3DUS) at simulation compared to 3DUS at treatment is an image
guidance option for partial breast irradiation (PBI). This study assessed if user dependence in acquiring and
contouring 3DUS (operator variability) contributed to variation in seroma shifts calculated for breast IGRT.
Methods: Eligible patients met breast criteria for current randomized PBI studies. 5 Operators participated in this
study. For each patient, 3 operators were involved in scan acquisitions and 5 were involved in contouring. At CT
simulation (CT1), a 3DUS (US1) was performed by a single radiation therapist (RT). 7 to 14 days after CT1 a second
CT (CT2) and 3 sequential 3DUS scans (US2a,b,c) were acquired by each of 3 RTs. Seroma shifts, between US1 and
US2 scans were calculated by comparing geometric centers of the seromas (centroids). Operator contouring
variability was determined by comparing 5 RT’s contours for a single image set. Scanning variability was assessed
by comparing shifts between multiple scans acquired at the same time point (US1-US2a,b,c). Shifts in seromas
contoured on CT (CT1-CT2) were compared to US data.
Results: From an initial 28 patients, 15 had CT visible seromas, met PBI dosimetric constraints, had complete US
data, and were analyzed. Operator variability contributed more to the overall variability in seroma localization than
the variability associated with multiple scan acquisitions (95% confidence mean uncertainty of 6.2 mm vs. 1.1 mm).
The mean standard deviation in seroma shift was user dependent and ranged from 1.7 to 2.9 mm. Mean seroma
shifts from simulation to treatment were comparable to CT.
Conclusions: Variability in shifts due to different users acquiring and contouring 3DUS for PBI guidance were
comparable to CT shifts. Substantial inter-observer effect needs to be considered during clinical implementation
of 3DUS IGRT.
Keywords: Breast cancer, 3D ultrasound, Image guided radiotherapyBackground
The target for partial breast irradiation (PBI) and boost
radiotherapy relies on definition of the seroma or healing
surgical bed plus a margin [1,2], but the ideal method
to define the target for PBI remains unclear [3]. Clin-
ical examination is inaccurate resulting in 50-80% of* Correspondence: alandry@ihis.org
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reproduction in any medium, provided the orthe seroma receiving inadequate dose [4]. Using surgi-
cal clips to define the target has been associated with a
higher recurrence rate [5], smaller volumes compared to
CT-delineated volumes [6], and clips are uncommonly
placed by surgeons. It has been proposed that daily cone
beam CT (CBCT) of the excision cavity is optimal during
external beam PBI [7], however, this is not unanimous
[8,9] and daily CBCT increases integral dose.
Ultrasound (US) provides good image quality in breast
tissue, is non-ionizing, and identifies the seroma in most
breast cancer patients [10,11]. One distinction between
3DUS and other image-guided radiotherapy (IGRT)Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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process that may result from scanning variability, patient
respiration, probe pressure, selected image settings, and
the chosen contouring strategy. In most clinical radiother-
apy departments it is likely that multiple operators would
be involved with the scanning and contouring tasks asso-
ciated with a breast cancer patient’s US guided treatment.
This study aimed to determine the extent to which oper-
ator variability in 3DUS acquisition and seroma contour-
ing contributed to differences calculated for breast IGRT.
Methods
Study subjects
Eligible subjects were women undergoing CT simulation
for adjuvant whole breast radiotherapy. Inclusion cri-
teria were age ≥ 40 years, pathologically confirmed ductal
carcinoma in-situ (DCIS) or invasive ductal breast can-
cer ≤ 3 cm diameter treated with breast conserving
surgery with negative margins. Women were excluded
if they had mastectomy, lobular histology, multicentric
disease, bilateral breast cancer, or if their CT simulation
was > 14 weeks after the last breast surgery. This study
was approved by the institutional research ethics board.
All subjects provided written informed consent.
3D ultrasound system
3DUS was performed using the Clarity (Clarity™, Elekta
Soft Tissue Visualization, Montreal, Quebec) US system
that consists of three components: a 10-MHz probe with a
linear transducer array to collect US images; a computer
system to reconstruct and display the images, and an infra-
red imaging system to track the location of the US probe
in the CT room. The US and CT images were implicitly
registered through a shared common coordinate system.
The Clarity System is equipped with two different con-
touring platforms: [1] ‘Workstation Mode’, which is an off-
line platform (patient not present) that allows the observer
full latitude to visualize and contour the lumpectomy cavity
using several manual and semi-automated contouring tools
and [2] ‘Guide Mode’, an on-line platform (patient present)
which allows the observer to contour a live 3DUS acquisi-
tion using a manual approach, a 5-point semi automated
contouring approach, or by overlaying the patient’s position
reference volume (an imported 3DUS structure defined on
previous 3DUS) on the current 3DUS scan.
A daily quality assurance program was developed and im-
plemented to ensure the integrity of the Clarity System within
the CT simulator room was accurate to within 1.0 mm.
Image acquisition
Simulation (CT1 and US1)
At CT simulation patients were positioned on a breast
board with the ipsilateral arm abducted (Figure 1a). Radio-
opaque wire was used to mark the surgical scar and breastand radio-opaque skin markers were set on anterior mid-
line and right or left mid-axilla lines, half-way between the
superior and inferior border of the wired breast. The
co-ordinates of the LAP laser were recorded to ensure
consistent set-up on subsequent CT and US image acqui-
sitions. Standard 3 mm CT slices were obtained using a
dedicated CT-Sim (GE Lightspeed, 80 cm aperture). Im-
mediately following acquisition of the planning CT data
(CT1), while the patient was instructed not to move, the
CT couch was repositioned 500 mm inferior of the CT
origin. Scar wires were removed and a 3DUS (US1) was
acquired, in ‘Workstation Mode’, by a radiation therapists
using high viscosity gel to minimize breast deformation
and optimize image quality.
Image guidance (CT2 and US2a, b & c)
Patients returned 14–21 days after their initial planning
simulation. All patients were once again placed on the
breast board and radio-opaque markers were placed on
the skin reference tattoos. Patients were then aligned using
the LAP lasers, which were set using the initial planning
simulation recorded values. A second CT dataset (CT2)
was acquired using the CT simulation protocol described
previously. Following CT scanning, the patient was trans-
lated 500 mm and three sequential 3DUS image sets (total
of 3 US images = US2a, b&c) were acquired by three RTs
using the Clarity system in ‘Guide Mode’ (Figure 1b).
Image registration
CT1 and CT2 image sets were co-registered in ‘Work-
station Mode’ by a single radiation oncologist by first
applying an automated technique and then by adjust-
ing manually for fine tuning. US2a, 2b, and 2c were auto-
matically co-registered to US1 in Guide Mode using
the Clarity in-room coordinate system and LAP laser
co-ordinates.
Seroma contouring
CT1 and CT2 seromas were contoured “off-line” in
‘Workstation Mode’ by a single radiation oncologist ex-
perienced in partial breast radiotherapy. Similarly, US1 was
contoured “off-line” in ‘Workstation Mode’ by the study
RT who performed the initial 3DUS acquisition. US2a,
b&c were contoured “off-line” in ‘Guide Mode’ by five RTs
involved in the study to reproduce the conditions of 3DUS
image guidance at the time of treatment. To promote
consistency and speed, RTs were instructed to contour
US2, for comparison with US1, using the 5-point semi-
automated approach available in ‘Guide-Mode’ using the
positioning reference volume from US1 as a guide only.
Seroma shift calculation
The ‘seroma shift’ represents the change in patient pos-
ition required to align the seroma at the time of treatment
(a).  Step 1- Simulation
(b). Step 2 – Image guidance 
Figure 1 Image acquisition and guidance process. (a) Imaging acquisition process at simulation. A simulation CT was acquired (CT1) followed
by a single 3DUS scan (US1). US1 picture shows the 3D US probe. CT1 was contoured offline by a single RO while US1 was contoured by a single
RT. (b) Image guidance process at ‘treatment’. A second CT was acquired (CT2) followed by three subsequent 3DUS scans made by three
different RTs (US2a, US2b, US2c). CT2 was contoured by a single RO and a seroma shift was determined based on implicit registration of CT
coordinates. US2a, US2b, and US2c were each contoured by 5 RTs and a seroma shift was calculated by comparing each contour with the initial
US1. This study design allowed for an analysis of scanning variability (dashed line) and contouring variability (dotted line).
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tion (US1, CT1). Both CT and US shifts were deter-
mined in each of the Cartesian directions (Right/Left,
Anterior/Posterior, Superior/Inferior) by comparing the
centroid (geometric center of the seroma) contoured at
the time of image guidance to the centroid location
of the seroma contoured following simulation. Shift cal-
culations were made ‘off-line’. Calculated shifts were not
used to position the patient during the actual treatment
course.Statistical analysis
Subjects included in analysis
Subjects were excluded from analysis if they did not
meet PBI dosimetric constraints [12] or had poor ser-
oma clarity [11]. Seroma clarity on both CT1 and US1
was assessed using a previously described 6 point scale
(0 = no visible seroma to 5 = clear, homogeneous seroma
with sharp boundaries) [11]. Each seroma was assigned a
consensus score after joint review by a multidisciplinary
team (physics, radiation oncology, RT). A seroma clarity
Table 1 Clinical, pathologic and initial imaging
characteristics of consenting subjects (n = 28) and the
analyzed subset (n = 15)
Entire cohort Analysis cohort
n = 28 n = 15
Age (years)
Median (range) 68 (47–87) 72 (53–87)
Histology n (%)
Invasive Ductal 27 (96) 15 (100)
Ductal Carcinoma in Situ 1 (4) 0
Pathologic tumour size (cm)
Median (range) 1.2 (0.3 – 2.5) 1.4 (0.8 – 2.5)
Grade (Invasive Ductal) n (%)
I 8 (30) 6 (40)
II 16 60) 8 (53)
III 3 (11) 1(7)
Estrogen receptor status
Positive 26 (92.8) 14 (93.3)
Laterality
Right 12 (42.8) 6 (40.0)
Left 16 (57.2) 9 (60.0)
Seroma location
Inner/central 11 (39.3) 5(33.3)






Mean (range) 1732 (712 – 3877) 1429 (711 – 2088)
Seroma volume (cc)
Mean (range) 32 (7 – 157) 21 (6 – 50)
Seroma: breast ratio
Mean (range) 0.018 ± 0.015 0.0.015 ± 0.013
BCS to CT simulation* (weeks)
Mean (range) 8.8 (4.4 – 13.4) 9.5 (5.9 – 13.3)
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ties) was deemed too poor for PBI targeting and subjects
were excluded from analysis.
3DUS seroma shifts
US seroma shifts were determined by the five RTs on the
three subsequent US scans taken at the time of image
guidance (Figure 1b). For further investigation a vec-
tor defined by a spherical volume of interest with ra-
dius = [(R/L)2 + (A/P)2 + (S/I)2]0.5 was calculated. This
vector defines a three-dimensional region about which
the seroma centroid should be located. The vector ra-
dius is of clinical interest as it helps define potential
target margins.
Comparison with CT seroma shifts
Absolute mean shifts in each of the Cartesian directions
for seromas contoured on US (US1 – US2) were com-
pared to absolute mean shifts determined by CT (CT1-
CT2) for each patient. Shift vectors for seromas contoured
on US and CT were compared.
3DUS operator variability
ATwo-Way ANOVA at the 95% confidence level (α = 0.05)
was applied for each subject. Variability introduced by mul-
tiple 3DUS scan acquisitions (scanning variability) was
assessed for each patient by comparing the mean centroid
displacement between US2a, US2b, and US2c (Figure 1b).
Similarly, variability introduced by multiple operators con-
touring individual US images (operator variability) was
assessed by comparing centroid displacement determined
between operators on an individual US scan acquisition
(Figure 1b). ANOVA was used to determine mean intra-
operator and inter-operator seroma shifts for the entire
patient cohort and to compare the mean standard devi-
ation (SD) among observers.
Time requirements for 3D US IGRT
Estimates were recorded for the time taken to acquire
an US image at simulation (US1), to contour the initial
US (US1) offline, to acquire subsequent US images (US2a,
US2b, US2c), and to contour those images offline.
Results
3D US clarity and PBI eligibility
Clinical characteristics and factors affecting PBI planning
are outlined in Table 1. Of the 28 subjects who under-
went US1/CT1, 13 were excluded due to poor CT
seroma clarity, failure to meet dosimetric constraints or
incomplete US data acquisition (Figure 2) including one
patient with no identifiable seroma at the time of ultra-
sound, but a CT seroma clarity score of 4. No factors
that were predictive of poor CT seroma clarity, PBI plan-
ning failure, or poor US seroma clarity, were identified.Magnitude of 3D US shifts
Figure 3 shows the mean shifts in each of the Cartesian
directions for the 15 subjects using all operator and US
data. The minimum and maximum shifts in any direc-
tion were 0.2 mm and 10.5 mm respectively. Mean abso-
lute US shifts were 3.1 mm, 3.3 mm, and 3.5 mm for R/L,
A/P, and S/I directions respectively. Mean seroma shift
vectors ranged from 0.9 mm to 10.9 mm with a mean and
standard deviation of 6.6 mm and 2.6 mm respectively. Eight
of the 15 patients (53%) demonstrated a shift >5.0 mm in
at least one of the Cartesian directions. 10 of the 15
Figure 2 Consort diagram of patients eligible for study, reasons for exclusions and those included in final analysis.
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2 (13.3%) exceeded 10.0 mm.
Comparison with CT shifts
Mean shifts for CT1 to CT2 as determined by a single
RO were 2.4 mm, 3.3 mm, 2.2 mm for R/L, A/P, and S/I















Figure 3 Mean US seroma shifts and vectors; R/L (white); A/P (grey); S
the mean of 15 shift calculations per patient (5 RTs × 3US).determined by US. Mean seroma shift vectors for CT
ranged from 0.5 mm to 11.7 mm with a mean and standard
deviation of 5.5 mm and 2.8 mm respectively. Nine subjects
(60.0%) demonstrated a vector shift > 5.0 mm and one pa-
tient (6.7%) exceeded 10.0 mm when CT was employed for
image guidance. The mean and standard deviation for the
































































US and CT Shifts - Sup/Inf
US2-US1
CT2-CT1
Figure 4 Comparisons of US and CT shifts in the (a) Right/Left, (b) Ant/Post, and (c) Sup/Inf directions. Error bars represent the standard
deviation among the US2a, 2b, and 2c shifts relative to US1.
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population. However, Figure 4 shows that on a patient by
patient basis shifts determined using CT or US demon-
strated no statistical correlation.3DUS scanning and operator variability
Table 2 shows that seroma shifts determined from mul-
tiple scan acquisitions (scanning variability) were sta-
tistically indistinguishable (p = 0.42) with an expected
standard error in the mean of 0.6 mm in any direction.
Over an interval of ± 1.1 mm the seroma shift could be de-
tected with confidence (α = 0.05) on multiple US scans.
Seroma shifts determined between operators on the same
US scan (operator variability) were statistically indistin-
guishable (p = 0.19) with an expected standard error in
the mean from repeated shift calculations on different
US scans being 3.2 mm in any direction. Over an interval
of ± 6.2 mm the seroma shift could be detected with
confidence (α = 0.05) by different operators on the same
US scan.
ANOVA was employed to calculate standard devia-
tions in mean seroma shifts. Inter-operator standard
deviation means were 2.6 mm, 2.1 mm, and 3.0 mm for
R/L, A/P, and S/I directions respectively. Intra-operator
SD means were 2.2 mm, 2.1 mm, and 2.8 mm for R/L,
A/P, and S/I directions respectively. A substantial oper-
ator effect was observed in the intra-operator variability
in seroma shift determination (Figure 5a). SD in seroma
shifts between operator 1 and operator 5 differed by a
factor of almost 2 in all directions. Differences between
mean US shifts for each operator and the CT shifts cal-
culated by a single RO demonstrate that the operators
with the least variable US results also correlate better
with the CT results (Figure 5b).Time requirements for 3D US IGRT
The mean and SD time necessary to acquire the US
image taken at simulation (US1) was 13 ± 4 minutes.
The mean and SD time taken to contour the US1 offline
was 7 ± 3 minutes. The mean and SD time taken to ac-
quire and contour each of the US images offline using
the semi-automated ‘Guide Mode’ as the surrogate for
treatment (US2a, US2b, US2c) was 11 ± 4 minutes.Table 2 ANOVA results for variability in seroma shift
determination introduced as a result of multiple US scan
acquisitions (scanning variability) and multiple operators





Standard error in measurement (mm) 0.6 3.2
95% confidence interval (mm) 1.1 6.2
P-value 0.42 0.19Discussion
One concern for the use of US as a tool for image guid-
ance is that US scanning involves a certain pressure that
can cause the breast tissue to deform at the time of im-
aging. However, several studies have examined the effi-
cacy of 3DUS for daily localization of the surgical bed
and have reported good correlation of 3DUS with CT in
its ability to localize and track target displacements
[10,11]. The current study sought to determine the ex-
tent to which operator variability in 3DUS acquisition
and seroma contouring contributed to seroma shift dif-
ferences calculated for breast IGRT.
In clinical practice it is likely that multiple operators
would be involved with the acquisition, contouring, and
patient repositioning if 3DUS IGRT was utilized. There
are many factors that may confound the accuracy of the
localization of the target between fractions. We have
defined “scanning” variability to encompass those poten-
tial sources of variability related specifically to image
acquisition. Scanning variation included differences in
US scan settings, patient breathing during image acquisi-
tion, probe pressure [12] and scanning direction. Scan-
ning variability was assessed by comparing seroma shifts
between multiple 3DUS scans. Similarly, we have de-
fined “operator” variability to encompass those poten-
tial sources of variability related specifically to the seroma
contouring. Contouring variation included image window
and level settings, contouring strategy, and selection of
the interpolation algorithm used for 3D contour ex-
trapolation. To reduce contouring variation, the 5-point
semi-automated approach, which proved to be the most
consistent and accurate contouring method in a prelimin-
ary study, was chosen for use in this study. Despite this
attempt to standardize the approach to contouring our re-
sults show that contouring variability contributes more sig-
nificantly to the overall variability in seroma localization
than the variability associated with multiple scan acquisi-
tions. The data suggest that at the level of 95% confidence
contouring variability contributes a mean uncertainly of
6.2 mm in the determination of the seroma location com-
pared to a mean uncertainty of 1.1 mm contributed by the
variability from multiple scan acquisitions.
Our results demonstrate a clear difference between the
RT operators that participated in the study. Operators
with the least variable 3DUS results had better correl-
ation with seroma shifts determined using CT. Opera-
tors all had similar levels of experience, were all trained
in the same manner, and were not systematically moni-
tored throughout the scan acquisition or contouring.
Therefore, suggesting what technique or process allowed
some therapists to systematically arrive at better results
than others would purely be speculative. However, the
factor of two observed in the standard deviation in seroma
shifts between the most extreme operators provides
(a)
(b)
Figure 5 Comparison of intra-operator variability on US to CT shifts. (a) An operator effect was observed in the intra-operator variability
(shift standard deviation) in seroma shift determination. (b) Differences between mean US shifts for each operator and the CT shifts calculated
by a single RO demonstrate that the operators with the least variable US results also correlate better with the CT results.
Landry et al. Radiation Oncology 2014, 9:35 Page 8 of 9
http://www.ro-journal.com/content/9/1/35sufficient motivation to further explore inter-operator pro-
cedural differences to improve the consistency of 3DUS
IGRT in practice.
In our study, the mean and SD seroma shift vectors
were 6.6 ± 2.6 mm and 5.5 ± 2.8 mm for 3DUS and CT
respectively. While this is suggestive of good correlation
between 3DUS and CT it disguises substantial variationbetween the 3DUS and CT shifts of an individual
patient. In fact, there was no correlation observed between
3DUS and CT when comparing individual Cartesian shifts.
The seroma shifts determined using 3DUS, however, are
comparable to CT being mindful that any discrepancies
observed are more reflective of measurement “noise” than
true differences between imaging modalities.
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PTV margin necessary to ensure proper coverage when
IGRT is not used. Wong et al. [10] used 3DUS IGRT for
20 patients and measured an average target displacement
of 10.8 ± 6.3 mm from the treatment plan. The authors
suggest that a margin of 23.4 mm (mean plus 2 SD) may
be needed for electron boost or PBI to ensure the target
is covered ≥ 95% of the time when IGRT is not used. We
measured a mean seroma shift vectors of 6.6 ± 2.6 mm.
This suggests that a margin of 11.8 mm may be needed
for electron boost or PBI to ensure that the target is cov-
ered ≥ 95% of the time when IGRT is not used. It should
be recognized, however, that of the 15 patients in our
study 10 (66%) demonstrated a vector shift > 5.0 mm and 2
(13.3%) exceeded 10.0 mm. Suggesting that a much larger
margin is required in the absence of IGRT. Additionally,
while the margins suggested by our results improve on the
results of Wong et al. [10] by almost a factor of two, this
may be attributed to stricter patient eligibility in our study.
The seroma shifts observed in our study were in many
cases in excess of the CTV to PTV growth used by Kirby
et al. [7] and those used in ongoing trials evaluating
external beam [13]. This emphasizes the need for daily
image guidance for PBI to avoid unreasonably large
margins or under-treatment of the CTV.
Conclusions
Variability introduced by multiple scan acquisitions or
by multiple operators contouring 3DUS images does not
contribute significantly to seroma shifts. Seroma shifts
for IGRT determined using 3DUS are of similar magnitude
to CT. 3DUS IGRT requires approximately 15 minutes at
simulation and 11 minutes per IGRT fraction at treatment.
An observed inter-operator effect suggests future work to
minimize variability and may improve the efficacy of 3DUS
as an IGRT tool for breast PBI.
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